These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 27034792)

  • 1. Lymph Node Number Predicts the Efficacy of Adjuvant Chemoradiotherapy in Node-Positive Endometrial Cancer Patients.
    Lee J; Yu T; Tsai MH
    Diagnostics (Basel); 2020 Jun; 10(6):. PubMed ID: 32512893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant radiation provides survival benefit for resected pancreatic adenocarcinomas of the tail.
    Jin WH; Hoffe SE; Shridhar R; Strom T; Venkat P; Springett GM; Hodul PJ; Pimiento JM; Meredith KL; Malafa MP; Frakes JM
    J Gastrointest Oncol; 2018 Jun; 9(3):487-494. PubMed ID: 29998014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemoradiotherapy for positive hepatic ductal margin on cholangiocarcinoma.
    Sugiura T; Uesaka K; Okamura Y; Ito T; Yamamoto Y; Ashida R; Ohgi K; Asakura H; Todaka A; Fukutomi A
    Ann Gastroenterol Surg; 2020 Jul; 4(4):455-463. PubMed ID: 32724890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-Free Resection Margin Distance in the Surgical Treatment of Node-Negative Squamous Cell Cancer of the Vulva Has No Impact on Survival: Analysis of a Large Patient Cohort in a Tertiary Care Center.
    Taran FA; Pasternak J; Staebler A; Rohner A; Neis F; Engler T; Oberlechner E; Schönfisch B; Juhasz-Böss I; Hartkopf AD; Brucker S; Walter CB
    Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved survival after palliative resection of unsuspected stage IV pancreatic ductal adenocarcinoma.
    Kim Y; Kim SC; Song KB; Kim J; Kang DR; Lee JH; Park KM; Lee YJ
    HPB (Oxford); 2016 Apr; 18(4):325-31. PubMed ID: 27037201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients.
    Osipov A; Nikolic O; Gertych A; Parker S; Hendifar A; Singh P; Filippova D; Dagliyan G; Ferrone CR; Zheng L; Moore JH; Tourtellotte W; Van Eyk JE; Theodorescu D
    Nat Cancer; 2024 Feb; 5(2):299-314. PubMed ID: 38253803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deeper insights into long-term survival heterogeneity of pancreatic ductal adenocarcinoma (PDAC) patients using integrative individual- and group-level transcriptome network analyses.
    Bhardwaj A; Josse C; Van Daele D; Poulet C; Chavez M; Struman I; Van Steen K
    Sci Rep; 2022 Jun; 12(1):11027. PubMed ID: 35773268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative CA19-9 levels predict disease-free survival and overall survival in pancreatic adenocarcinoma patients after resection.
    Guan S; Chen Y; Han Q; Deng G; Wang Y; Shi Y; Dai G
    Transl Cancer Res; 2019 Jun; 8(3):811-820. PubMed ID: 35116819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Undertreatment of Pancreatic Cancer: Role of Surgical Pathology.
    Olecki EJ; Stahl K; Peng JS; Dixon M; Gusani NJ; Shen C
    Ann Surg Oncol; 2021 Mar; 28(3):1581-1592. PubMed ID: 32851518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical margins for duodenopancreatectomy.
    Coppola R; Cartillone M; Borzomati D; Nappo G; Valeri S; Petitti T; Perrone G
    Updates Surg; 2016 Sep; 68(3):279-285. PubMed ID: 27778242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant radiotherapy and lymph node status for pancreatic cancer: results of a study from the Surveillance, Epidemiology, and End Results (SEER) Registry Data.
    Opfermann KJ; Wahlquist AE; Garrett-Mayer E; Shridhar R; Cannick L; Marshall DT
    Am J Clin Oncol; 2014 Apr; 37(2):112-6. PubMed ID: 23211221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma?
    Hakeem AR; Marangoni G; Chapman SJ; Young RS; Nair A; Hidalgo EL; Toogood GJ; Wyatt JI; Lodge PA; Prasad KR
    Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):1047-54. PubMed ID: 25051217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant Radiochemotherapy versus Chemotherapy Alone for Gastric Cancer: Implications for Target Definition.
    Xu J; Zhu J; Wei Q
    J Cancer; 2019; 10(2):458-466. PubMed ID: 30719140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of margin status and lymphadenectomy on clinical outcomes in resected pancreatic adenocarcinoma: implications for adjuvant radiotherapy.
    Osipov A; Naziri J; Hendifar A; Dhall D; Rutgers JK; Chopra S; Li Q; Tighiouart M; Annamalai A; Nissen NN; Tuli R
    J Gastrointest Oncol; 2016 Apr; 7(2):239-47. PubMed ID: 27034792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redefining the Positive Margin in Pancreatic Cancer: Impact on Patterns of Failure, Long-Term Survival and Adjuvant Therapy.
    Osipov A; Nissen N; Rutgers J; Dhall D; Naziri J; Chopra S; Li Q; Hendifar AE; Tuli R
    Ann Surg Oncol; 2017 Nov; 24(12):3674-3682. PubMed ID: 28871564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
    Kim YS; Hwang IG; Park SE; Go SI; Kang JH; Park I; Oh SY; Ji JH; Song HN; Park SH; Kim ST; Park JO
    Cancer Chemother Pharmacol; 2016 May; 77(5):979-85. PubMed ID: 27017615
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.